Small Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Small Pharma's estimated annual revenue is currently $8.8M per year.
- Small Pharma's estimated revenue per employee is $201,000
Employee Data
- Small Pharma has 44 Employees.
Small Pharma's People
| Name | Title | Email/Phone |
|---|
Small Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $22.9M | 114 | 4% | £18M | N/A |
#2 | $8.4M | 42 | 0% | N/A | N/A |
#3 | $69.7M | 347 | 12% | N/A | N/A |
#4 | $234.1M | 728 | 5% | $5.7M | N/A |
#5 | $165.2M | 822 | 2% | N/A | N/A |
#6 | $19.3M | 96 | 7% | N/A | N/A |
#7 | $28.7M | 143 | 17% | N/A | N/A |
#8 | $69.7M | 347 | 21% | N/A | N/A |
#9 | $24.1M | 120 | 25% | N/A | N/A |
#10 | $62.1M | 309 | N/A | N/A | N/A |
What Is Small Pharma?
Small Pharma applies expert intellectual property design to guide academic discovery to commercial product. We operate a scalable model of outsourced drug development. We assemble specific expert teams to design and execute development programs with demonstrated track-records in all disciplines essential to their success. Our current project is a rapid-acting antidepressant with potential to transform depression treatment. Existing antidepressants take 6-12 weeks to work, and are ineffective in 40% of sufferers. Our DMT drug candidates have the potential to accelerate recovery through psychedelic assisted therapy.
keywords:N/AN/A
Total Funding
44
Number of Employees
$8.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Small Pharma News
Scangos has transitioned throughout his career from academia to a small company that was bought by Bayer AG. He then ran Exelixis, Inc. for 14...
Elsewhere in Roche's pharma department, biosimilars continue to wreak havocthough to a smaller magnitude than in prior quarters. Copycats to Roche's cancer...
Under the agreement, Iktos generative modelling technology will be implemented and applied to several Teijin Pharma's small molecule drug...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.2M | 44 | 16% | N/A |
#2 | $4.2M | 44 | 13% | N/A |
#3 | $6.1M | 44 | 7% | N/A |
#4 | $8.8M | 44 | 5% | N/A |
#5 | $8.6M | 44 | 29% | N/A |
